Nuclear Medicine | Oncology | Radiology Automated PD-L1 status prediction in lung cancer with multi-modal PET/CT fusion. July 19, 2024
Oncology | Pathology An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability. March 13, 2024
Artificial Intelligence | Immunology | Oncology | Pathology BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration. March 28, 2023
Immunology | Oncology | Precision Medicine | Radiology Self-supervised contrastive learning using CT images for PD-1/PD-L1 expression prediction in hepatocellular carcinoma. March 20, 2023
Artificial Intelligence | Immunotherapy | Pathology Development of an automated combined positive score prediction pipeline using artificial intelligence on multiplexed immunofluorescence images. December 12, 2022
Oncology | Pathology Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer. November 8, 2022
Bioinformatics | Immunology | Oncology PDL1Binder: Identifying programmed cell death ligand 1 binding peptides by incorporating next-generation phage display data and different peptide descriptors. August 2, 2022
Oncology | Pathology Artificial Intelligence-Assisted Score Analysis for Predicting the Expression of the Immunotherapy Biomarker PD-L1 in Lung Cancer. July 19, 2022
Oncology | Pulmonology | Radiology Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images. March 7, 2022
Medical Informatics | Oncology | Pathology Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer. November 17, 2021
Oncology | Pathology Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma. September 10, 2021
Oncology | Pathology Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images. September 20, 2019